CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C16804 | BRD-K45205755 | BRD-K45205755 | -- | -- | -- | Details |
| C16805 | BRD-K45216862 | BRD-K45216862 | -- | -- | -- | Details |
| C16806 | BRD-K45217009 | BRD-K45217009 | -- | -- | -- | Details |
| C16807 | BRD-K45221651 | BRD-K45221651 | -- | -- | -- | Details |
| C16808 | BRD-K45222065 | BRD-K45222065 | -- | -- | -- | Details |
| C16809 | BRD-K45222498 | BRD-K45222498 | -- | -- | -- | Details |
| C16810 | BRD-K45223163 | BRD-K45223163 | -- | -- | -- | Details |
| C16811 | BRD-K45230579 | BRD-K45230579 | -- | -- | -- | Details |
| C16812 | BRD-K45231555 | BRD-K45231555 | -- | -- | -- | Details |
| C16813 | BRD-K45231869 | BRD-K45231869 | -- | -- | -- | Details |
| C16814 | BRD-K45232279 | BRD-K45232279 | -- | -- | -- | Details |
| C16815 | BRD-K45235808 | BRD-K45235808 | -- | -- | -- | Details |
| C16816 | BRD-K45237033 | BRD-K45237033 | -- | -- | -- | Details |
| C16817 | BRD-K45245001 | BRD-K45245001 | -- | -- | -- | Details |
| C16818 | BRD-K45245728 | ursodeoxycholyltaurine | -- | -- | -- | Details |
| C16819 | BRD-K45251081 | BRD-K45251081 | -- | -- | -- | Details |
| C16820 | BRD-K45252063 | clofibrate | PPARA | PPAR receptor agonist | -- | Details |
| C16821 | BRD-K45252909 | BRD-K45252909 | -- | -- | -- | Details |
| C16822 | BRD-K45253154 | SD-6-035-A7 | -- | -- | -- | Details |
| C16823 | BRD-K45256078 | BRD-K45256078 | -- | -- | -- | Details |
| C16824 | BRD-K45258986 | BRD-K45258986 | -- | -- | -- | Details |
| C16825 | BRD-K45265701 | BRD-K45265701 | -- | -- | -- | Details |
| C16826 | BRD-K45265806 | BRD-K45265806 | -- | -- | -- | Details |
| C16827 | BRD-K45271289 | BRD-K45271289 | -- | -- | -- | Details |
| C16828 | BRD-K45272675 | BRD-K45272675 | -- | -- | -- | Details |
| C16829 | BRD-K45275534 | betrixaban | F10 | Coagulation inhibitor | -- | Details |
| C16830 | BRD-K45278408 | BRD-K45278408 | -- | -- | -- | Details |
| C16831 | BRD-K45282594 | BRD-K45282594 | -- | -- | -- | Details |
| C16832 | BRD-K45282766 | BRD-K45282766 | -- | -- | -- | Details |
| C16833 | BRD-K45289917 | BRD-K45289917 | -- | -- | -- | Details |
| C16834 | BRD-K45293975 | 7-hydroxystaurosporine | CDK4; CHEK1; CHEK2; PDPK1; PRKCA; CDK1 | CDK inhibitor; CHK inhibitor; PKC inhibitor | 7-HYDROXYSTAUROSPORINE | Details |
| C16835 | BRD-K45295352 | BRD-K45295352 | -- | -- | -- | Details |
| C16836 | BRD-K45296539 | ZD-7114 | ADRB3 | Adrenergic receptor agonist | -- | Details |
| C16837 | BRD-K45303727 | BRD-K45303727 | -- | -- | -- | Details |
| C16838 | BRD-K45307260 | BRD-K45307260 | -- | -- | -- | Details |
| C16839 | BRD-K45307499 | BRD-K45307499 | -- | -- | -- | Details |
| C16840 | BRD-K45307863 | BRD-K45307863 | -- | -- | -- | Details |
| C16841 | BRD-K45308677 | BRD-K45308677 | -- | -- | -- | Details |
| C16842 | BRD-K45315294 | BRD-K45315294 | -- | -- | -- | Details |
| C16843 | BRD-K45318035 | BRD-K45318035 | -- | -- | -- | Details |
| C16844 | BRD-K45319408 | BRD-K45319408 | -- | -- | -- | Details |
| C16845 | BRD-K45319476 | BRD-K45319476 | -- | -- | -- | Details |
| C16846 | BRD-K45319854 | BRD-K45319854 | -- | -- | -- | Details |
| C16847 | BRD-K45322187 | BRD-K45322187 | -- | -- | -- | Details |
| C16848 | BRD-K45327589 | BRD-K45327589 | -- | -- | -- | Details |
| C16849 | BRD-K45328741 | BRD-K45328741 | -- | -- | -- | Details |
| C16850 | BRD-K45330754 | BRD-K45330754 | -- | -- | diethylstilbestrol | Details |
| C16851 | BRD-K45333259 | BRD-K45333259 | -- | -- | -- | Details |
| C16852 | BRD-K45336346 | BRD-K45336346 | -- | -- | -- | Details |
| C16853 | BRD-K45339826 | BRD-K45339826 | -- | -- | -- | Details |
| C16854 | BRD-K45340761 | BRD-K45340761 | -- | -- | -- | Details |
| C16855 | BRD-K45342423 | BRD-K45342423 | -- | -- | -- | Details |
| C16856 | BRD-K45343543 | BRD-K45343543 | -- | -- | -- | Details |
| C16857 | BRD-K45347683 | BRD-K45347683 | -- | -- | -- | Details |
| C16858 | BRD-K45348630 | BRD-K45348630 | -- | -- | -- | Details |
| C16859 | BRD-K45350681 | BRD-K45350681 | -- | -- | -- | Details |
| C16860 | BRD-K45355657 | BRD-K45355657 | -- | -- | -- | Details |
| C16861 | BRD-K45355730 | BRD-K45355730 | -- | -- | -- | Details |
| C16862 | BRD-K45356824 | SA-1973497 | -- | -- | -- | Details |
| C16863 | BRD-K45358679 | BRD-K45358679 | -- | -- | -- | Details |
| C16864 | BRD-K45358881 | BRD-K45358881 | -- | -- | -- | Details |
| C16865 | BRD-K45361857 | BRD-K45361857 | -- | -- | -- | Details |
| C16866 | BRD-K45367466 | BRD-K45367466 | -- | -- | -- | Details |
| C16867 | BRD-K45371861 | BRD-K45371861 | -- | -- | -- | Details |
| C16868 | BRD-K45375659 | BRD-K45375659 | -- | -- | -- | Details |
| C16869 | BRD-K45378289 | BRD-K45378289 | -- | -- | -- | Details |
| C16870 | BRD-K45380779 | BRD-K45380779 | -- | -- | -- | Details |
| C16871 | BRD-K45383235 | BRD-K45383235 | -- | -- | -- | Details |
| C16872 | BRD-K45383509 | BRD-K45383509 | -- | -- | -- | Details |
| C16873 | BRD-K45386827 | BRD-K45386827 | -- | -- | -- | Details |
| C16874 | BRD-K45392462 | BRD-K45392462 | -- | -- | -- | Details |
| C16875 | BRD-K45394633 | BRD-K45394633 | -- | -- | -- | Details |
| C16876 | BRD-K45398957 | BRD-K45398957 | -- | -- | -- | Details |
| C16877 | BRD-K45399554 | CAM-9-027-3 | -- | -- | -- | Details |
| C16878 | BRD-K45400577 | BRD-K45400577 | -- | -- | -- | Details |
| C16879 | BRD-K45401373 | betulinic-acid | GPBAR1 | Apoptosis stimulant; Caspase activator; NFkB pathway activator; HIV integrase inhibitor; Topoisomerase inhibitor; Diacylglycerol O acyltransferase inhibitor; SARS coronavirus 3C-like protease inhibitor | -- | Details |
| C16880 | BRD-K45409613 | BRD-K45409613 | -- | -- | -- | Details |
| C16881 | BRD-K45421483 | BRD-K45421483 | -- | -- | -- | Details |
| C16882 | BRD-K45428339 | BRD-K45428339 | -- | -- | -- | Details |
| C16883 | BRD-K45429601 | BRD-K45429601 | -- | -- | -- | Details |
| C16884 | BRD-K45431864 | BRD-K45431864 | -- | -- | -- | Details |
| C16885 | BRD-K45435259 | SCH-23390 | DRD1; DRD5; HTR2C | Dopamine receptor antagonist | -- | Details |
| C16886 | BRD-K45437867 | BRD-K45437867 | -- | -- | 5-methylfurmethiodide | Details |
| C16887 | BRD-K45440108 | BRD-K45440108 | -- | -- | -- | Details |
| C16888 | BRD-K45442578 | BRD-K45442578 | -- | -- | -- | Details |
| C16889 | BRD-K45443261 | BRD-K45443261 | -- | -- | -- | Details |
| C16890 | BRD-K45443730 | BRD-K45443730 | -- | -- | -- | Details |
| C16891 | BRD-K45446451 | JZL-184 | -- | -- | -- | Details |
| C16892 | BRD-K45466167 | BRD-K45466167 | -- | -- | -- | Details |
| C16893 | BRD-K45466793 | BRD-K45466793 | -- | -- | -- | Details |
| C16894 | BRD-K45471346 | BRD-K45471346 | -- | -- | -- | Details |
| C16895 | BRD-K45472161 | BRD-K45472161 | -- | -- | -- | Details |
| C16896 | BRD-K45472595 | BRD-K45472595 | -- | -- | -- | Details |
| C16897 | BRD-K45475981 | BRD-K45475981 | -- | -- | -- | Details |
| C16898 | BRD-K45479396 | BP-554 | HTR1A | Serotonin receptor agonist | -- | Details |
| C16899 | BRD-K45480436 | BRD-K45480436 | -- | -- | -- | Details |
| C16900 | BRD-K45481924 | BRD-K45481924 | -- | -- | -- | Details |
| C16901 | BRD-K45485804 | BRD-K45485804 | -- | -- | -- | Details |
| C16902 | BRD-K45490439 | BRD-K45490439 | -- | -- | -- | Details |
| C16903 | BRD-K45493873 | BRD-K45493873 | -- | -- | -- | Details |